Home » Topics » Regulatory

Regulatory
RSS

Nexium completes European mutual recognition procedure for new indications

Sep. 20, 2004

Vioxx approved for once-daily treatment of juvenile rheumatoid arthritis

Sep. 9, 2004

Proscar approved for new indication in Canada

Sep. 7, 2004

Clarinex syrup approved for use in children with allergies, hives

Sep. 3, 2004

sNDA submission for Merrem for complicated skin and skin structure infections

Aug. 5, 2004

Aldara receives approval for superficial basal cell carcinoma

July 20, 2004

Lyrica approved in E.U.

July 12, 2004

Eisai launches Apnission in Japan

July 6, 2004

Arava approved in Europe for active psoriatic arthritis

July 2, 2004

Change of indications for phase II trials of KOS-862

June 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...